受强制性开放获取政策约束的文章 - John Krauss了解详情
可在其他位置公开访问的文章：32 篇
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
RC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ...
The Lancet Oncology 21 (2), 271-282, 2020
强制性开放获取政策： US National Institutes of Health, Alex's Lemonade Stand
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ...
New England Journal of Medicine 383 (13), 1207-1217, 2020
强制性开放获取政策： US National Institutes of Health, Damon Runyon Cancer Research Foundation …
Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy
J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ...
Journal of clinical oncology 40 (23), 2546-2556, 2022
强制性开放获取政策： US National Institutes of Health
Rituximab extended schedule or re-treatment trial for low–tumor burden follicular lymphoma: Eastern Cooperative Oncology Group protocol E4402
BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ...
Journal of Clinical Oncology 32 (28), 3096-3102, 2014
强制性开放获取政策： US National Institutes of Health
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
JH Uhm, KV Ballman, W Wu, C Giannini, JC Krauss, JC Buckner, ...
International Journal of Radiation Oncology* Biology* Physics 80 (2), 347-353, 2011
强制性开放获取政策： US National Institutes of Health
Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial
FS Verheij, DM Omer, H Williams, ST Lin, LX Qin, JT Buckley, ...
Journal of Clinical Oncology 42 (5), 500-506, 2024
强制性开放获取政策： US National Institutes of Health
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy
DH Hovelson, CJ Liu, Y Wang, Q Kang, J Henderson, A Gursky, ...
Oncotarget 8 (52), 89848, 2017
强制性开放获取政策： US Department of Defense, US National Institutes of Health
315O sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase ib full expansion cohort
Y Kuboki, R Yaeger, MG Fakih, JH Strickler, T Masuishi, EJ Kim, ...
Annals of Oncology 33, S680-S681, 2022
强制性开放获取政策： US National Institutes of Health
Self-guided online cognitive behavioral strategies for chemotherapy-induced peripheral neuropathy: a multicenter, pilot, randomized, wait-list controlled trial
R Knoerl, EML Smith, DL Barton, DA Williams, JE Holden, JC Krauss, ...
The Journal of Pain 19 (4), 382-394, 2018
强制性开放获取政策： Damon Runyon Cancer Research Foundation
Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402
ME Williams, F Hong, RD Gascoyne, LI Wagner, JC Krauss, ...
British journal of haematology 173 (6), 867-875, 2016
强制性开放获取政策： US National Institutes of Health
Anxiety and health-related quality of life among patients with low–tumor burden Non-Hodgkin lymphoma randomly assigned to two different Rituximab Dosing Regimens: results From …
LI Wagner, F Zhao, F Hong, ME Williams, RD Gascoyne, JC Krauss, ...
Journal of Clinical Oncology 33 (7), 740-748, 2015
强制性开放获取政策： US National Institutes of Health
Quantitating and assessing interoperability between electronic health records
EV Bernstam, JL Warner, JC Krauss, E Ambinder, WS Rubinstein, ...
Journal of the American Medical Informatics Association 29 (5), 753-760, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Emerging systemic therapies for colorectal cancer
CM Veenstra, JC Krauss
Clinics in Colon and Rectal Surgery 31 (03), 179-191, 2018
强制性开放获取政策： US National Institutes of Health
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
Y Kuboki, M Fakih, J Strickler, R Yaeger, T Masuishi, EJ Kim, CM Bestvina, ...
Nature medicine 30 (1), 265-270, 2024
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Is the problem list in the eye of the beholder? An exploration of consistency across physicians
JC Krauss, PS Boonstra, AV Vantsevich, CP Friedman
Journal of the American Medical Informatics Association 23 (5), 859-865, 2016
强制性开放获取政策： US National Institutes of Health
An automated intervention did not improve adherence to oral oncolytic agents while managing symptoms: Results from a two-arm randomized controlled trial
A Sikorskii, CW Given, BA Given, E Vachon, JC Krauss, M Rosenzweig, ...
Journal of Pain and Symptom Management 56 (5), 727-735, 2018
强制性开放获取政策： US National Institutes of Health
Side effects, self-management activities, and adherence to oral anticancer agents
Y Jiang, KE Wickersham, X Zhang, DL Barton, KB Farris, JC Krauss, ...
Patient preference and adherence, 2243-2252, 2019
强制性开放获取政策： US National Institutes of Health
A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia
KP High, D Case, D Hurd, B Powell, G Lesser, AR Falsey, R Siegel, ...
The journal of supportive oncology 10 (5), 195, 2012
强制性开放获取政策： US National Institutes of Health
Development and characteristics of a multidisciplinary colorectal cancer clinic
JV Vu, AM Morris, LH Maguire, AC De Roo, A Mukkamala, JC Krauss, ...
The American Journal of Surgery 221 (4), 826-831, 2021
强制性开放获取政策： US National Institutes of Health
O-12 NCI9673 (part B): a multi-institutional ETCTN randomized phase II study of nivolumab with or without Ipilimumab in refractory, metastatic squamous cell carcinoma of the …
V Morris, K Ciombor, B Polite, S Mukherjee, J Krauss, A Shields, ...
Annals of Oncology 34, S185-S186, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定